Eleven substituted tricyclic quinazolines and their synthetic precursors were tested for antibacterial effects. 3-Chloromethylcarbonyl-2-methylquinazolin-4-thione and 5-phenyl-2,3-dihydro-1,2,4-triazolo[4,3-c]quinazolin-3-one had the highest antibacterial effect against Bacillus subtilis, the MIC values being 50 mg/L. Two tested derivatives were more active against Pseudomonas aeruginosa than ampicillin, the IC50 values being 80 and 100 mg/L. The most effective derivatives contained in the structure generally pharmacologically active chromophores--methyl group in position 2 and a chloromethyl configuration on the carbonyl group in position 3.

Department of Biochemistry and Microbiology Faculty of Chemical Technology Slovak University of Technology Bratislava Slovakia

Zobrazit více v PubMed

Arch Pharm (Weinheim). 1990 Oct;323(10):833-6 PubMed

Farmaco. 1990 Apr;45(4):431-8 PubMed

Folia Microbiol (Praha). 1995;40(6):611-4 PubMed

Anticancer Drugs. 1997 Jan;8(1):3-16 PubMed

Farmaco. 1995 Dec;50(12):857-66 PubMed

Folia Biol (Praha). 1997;43(2):83-9 PubMed

J Chem Technol Biotechnol. 1992;53(4):329-36 PubMed

J Med Chem. 1986 Nov;29(11):2403-9 PubMed

Folia Microbiol (Praha). 1998;43(6):679-82 PubMed

J Med Chem. 1996 Mar 29;39(7):1433-7 PubMed

In vitro antimicrobial activity of 3,4-dihydro-s-triazinobenzimidazole derivatives

Antibacterial effects of trisubstituted quinazoline derivatives